Mergers and Acquisitions - Huatian Technology is planning to acquire Huy Microelectronics, a subsidiary of its controlling shareholder, through a share issuance and cash payment, which is expected to constitute a related party transaction but not a major asset restructuring. The company's stock will be suspended from trading starting September 25 [1] - Dalong Real Estate's subsidiary intends to acquire 60% equity of Beijing Chengzhu Real Estate Development Co., Ltd. from Beijing Shunyi New Town Development Co., Ltd. to enhance project reserves and operational capabilities [2] - Yong'an Pharmaceutical plans to acquire 49.2% equity of its subsidiary Hubei Ling'an Technology Co., Ltd. from minority shareholders for 27 million yuan, aiming for full ownership [3] - Rongxin Culture's wholly-owned subsidiary intends to acquire 51% equity of Wuhan Youxue Baobei Book Co., Ltd. for 16.32 million yuan, which will be consolidated into the company's financial statements post-transaction [4] Shareholding Changes - Huyou Pharmaceutical's shareholder Wang Xiaopeng plans to reduce his stake by up to 3%, equivalent to a maximum of 12.708 million shares [5] - Beimo High-tech's shareholder Chen Jianfeng intends to reduce his stake by up to 2.49%, which amounts to a maximum of 8.2666 million shares [6] - Donghua Energy's controlling shareholder, Mansen Energy (Zhangjiagang), has increased its stake by 0.34%, acquiring 5.3093 million shares for approximately 45.6488 million yuan [7] Risk Matters - Zhangjiang Hi-Tech has announced a potential irrational speculation risk as its stock price has deviated significantly from industry peers and the Shanghai Composite Index, with a cumulative price increase of 20% over three consecutive trading days [8] - *ST Gaohong faces a risk of delisting as its stock price has been below 1 yuan for 18 consecutive trading days, with a potential delisting if the market capitalization remains below 500 million yuan for 20 consecutive trading days [9] - *ST Yatai's controlling shareholder's voting rights have decreased due to a forced sale of shares by a court, although this will not lead to a change in control or governance structure at this time [10]

Group 1 - Donghua Energy's Masen increased its stake by 0.34% [1] - Guoxin Technology's shareholders plan to reduce their holdings by up to 4.5% [1] - Guoguang Electric's shareholders, including Guozhiguang and Tianyi Venture Capital, intend to reduce their holdings by up to 3.85% [1] Group 2 - Xincheng Technology's four shareholders plan to reduce their holdings by 2.0316% in March [1] - Yujing Co., Ltd.'s shareholder Que Shiquan Li No. 1 intends to reduce its holdings by no more than 4.28 million shares [1] - Huiyu Pharmaceutical's Wang Xiaopeng plans to reduce his holdings by 3% over three months [1] Group 3 - Huaxi Securities' Jianan Spring Company plans to reduce its holdings by 1% within three months [1] - Beimo Gaoke's Chen Jianfeng intends to reduce his holdings by 2.49% [1] - Maiqu'er's shareholders plan to reduce their total shareholding by no more than 2% [1] Group 4 - Huadong Heavy Machinery's Tianchen Jinting No. 1 intends to reduce its holdings by 1.00% [1] - Cangge Mining's Xinsha Hongyun Investment plans to reduce its holdings by 0.60% [1] - Shengke Communication's major fund's shareholding ratio has decreased to 15% [1]

（文章来源：证券日报） 证券日报网讯 9月24日晚间，北摩高科发布公告称，公司持股5%以上股东陈剑锋先生持有公司股份 33，066，586股，占公司总股本的9.96%，拟自本减持计划公告之日起15个交易日的3个月内（即2025 年10月24日至2026年1月23日，在此期间如遇法律、法规规定的窗口期则不减持）采取包括但不限于大 宗交易、集中竞价的方式减持公司股份不超过8，266，647股，不超过公司总股本的2.49%，不超过上 年末本人直接或间接所持公司股份总数的百分之二十五；公司现任高管杨昌坤先生持有公司股份448， 362股，占公司总股本的0.14%。拟自本减持计划公告之日起15个交易日的3个月内（即2025年10月24日 至2026年1月23日，在此期间如遇法律、法规规定的窗口期则不减持）采取包括但不限于大宗交易、集 中竞价的方式减持公司股份不超过112，091股，不超过公司总股本的0.03%，不超过上年末本人直接或 间接所持公司股份总数的百分之二十五。 ...

Group 1 - Shanghai Zhiyuan Hengyue plans to acquire 37% of the shares of Shangwei New Materials at a price of 7.78 yuan per share, requiring a maximum total funding of 1.16 billion yuan [1] - The acquisition period is set for 30 calendar days, from September 29, 2025, to October 28, 2025 [1] - Zhiyuan Hengyue and Zhiyuan Xinchuan intend to acquire at least 63.62% and up to 66.99% of Shangwei New Materials' shares [2] Group 2 - Heng Rui Pharmaceutical has signed a licensing agreement for the innovative drug SHRA1811, receiving an upfront payment of 18 million dollars and is eligible for up to 1.093 billion dollars in milestone payments [3] - The agreement aims to expand the overseas market for SHRA1811 and enhance the company's innovative brand and overseas performance [3] Group 3 - Tian Shili's subsidiary has received approval for clinical trials of TSL2109 capsules, a dual-target small molecule inhibitor for advanced solid tumors, with no similar drugs currently in clinical trials [4] - The cumulative R&D investment in TSL2109 capsules by Jiangsu Diyi has reached 24.6251 million yuan [4] Group 4 - Wanhui High-tech expects a net profit of 340 million to 420 million yuan for the first three quarters, representing a year-on-year growth of 69.81% to 109.77% [5]

格隆汇9月24日丨北摩高科(002985.SZ)公布，公司5%以上股东陈剑锋先生持有公司股份33,066,586股， 占公司总股本的9.96%，拟自本减持计划公告之日起15个交易日的3个月内（即2025年10月24日至2026 年1月23日，在此期间如遇法律、法规规定的窗口期则不减持）采取包括但不限于大宗交易、集中竞价 的方式减持公司股份不超过8,266,647股，不超过公司总股本的2.49%,不超过上年末本人直接或间接所持 公司股份总数的百分之二十五； 公司现任高管杨昌坤先生持有公司股份448,362股，占公司总股本的0.14%。拟自本减持计划公告之日起 15个交易日的3个月内（即2025年10月24日至2026年1月23日，在此期间如遇法律、法规规定的窗口期则 不减持）采取包括但不限于大宗交易、集中竞价的方式减持公司股份不超过112,091股，不超过公司总 股本的0.03%,不超过上年末本人直接或间接所持公司股份总数的百分之二十五。 ...

北摩高科（002985）(002985.SZ)公告，公司股东陈剑锋先生、高级管理人员杨昌坤先生拟减持公司股 份。陈剑锋拟减持数量不超过826.66万股(不超过公司总股本的2.49%);杨昌坤拟减持数量不超过11.21万 股(不超过北摩高科总股本的0.03%)。 ...

人民财讯9月24日电，北摩高科（002985）9月24日公告，公司持股9.96%的股东陈剑锋拟减持公司股份 不超过826.66万股，即不超过公司总股本的2.49%。 公司现任高管杨昌坤拟减持公司股份不超过11.21万股，即不超过公司总股本的0.03%。 ...

智通财经APP讯，北摩高科(002985.SZ)公告，公司股东陈剑锋先生、高级管理人员杨昌坤先生拟减持公 司股份。陈剑锋拟减持数量不超过826.66万股(不超过公司总股本的2.49%);杨昌坤拟减持数量不超过 11.21万股(不超过北摩高科总股本的0.03%)。 ...

北摩高科9月24日晚间公告，持股3306.66万股、占9.96%的股东陈剑锋拟于2025年10月24日至2026年1月 23日通过大宗交易、集中竞价减持不超过826.66万股，占公司总股本2.49%；持股44.84万股、占0.14% 的副总经理杨昌坤拟同期以同方式减持不超过11.21万股，占0.03%。减持股份来源为IPO前取得及上市 后利润分配送转股、二级市场增持的股份。 ...

格隆汇9月24日｜北摩高科公告，持股3306.66万股、占9.96%的股东陈剑锋拟于2025年10月24日至2026 年1月23日通过大宗交易、集中竞价减持不超过826.66万股，占公司总股本2.49%；持股44.84万股、占 0.14%的副总经理杨昌坤拟同期以同方式减持不超过11.21万股，占0.03%。减持股份来源为IPO前取得及 上市后利润分配送转股、二级市场增持的股份。 ...